SOPHiA GENETICS (SOPH) Change in Receivables (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Change in Receivables data on file, last reported at -$6.6 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Receivables fell 419.1% year-over-year to -$6.6 million; the trailing twelve-month figure through Dec 2025 stood at -$6.6 million (down 212.07% YoY), and the FY2025 full-year result was -$6.6 million, down 212.07% from the prior year.
• Change in Receivables retreated to -$6.6 million in Q4 2025, from $1.3 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $3.0 million in Q4 2021 to a low of -$6.6 million in Q4 2025.
• A 5-year average of -$203650.0 and a median of $180000.0 in 2021 frame the typical range for Change in Receivables.
• Across the five-year window, Change in Receivables surged 478.37% in 2021 and plunged 158350.0% in 2023, its largest moves.
• Tracing SOPH's Change in Receivables over 5 years: stood at $3.0 million in 2021, then sank by 31.91% to $2.0 million in 2022, then sank by 278.77% to -$3.6 million in 2023, then soared by 157.43% to $2.1 million in 2024, then tumbled by 419.1% to -$6.6 million in 2025.
• Business Quant data shows SOPH's Change in Receivables at -$6.6 million in Q4 2025, $1.3 million in Q3 2025, and $1.7 million in Q2 2025.